DexCom, Inc. (DXCM) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

DexCom, Inc. (DXCM) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

DXCM

Market Closed

DexCom, Inc.

NASDAQHealthcare Medical - Devices

10.20K employees

CEO: Jacob Steven Leach

Founded: 2005

$72.47

+$0.00(+NaN%)

Market Cap

27.96B

Beta

1.44

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: DexCom’s current price exceeds the PERT-weighted fair value by 14.8%, indicating potential overvaluation. High financial health scores contrast with Monte Carlo downside risk of 94.4% below current price, reflecting volatility and downside exposure. Valuations vary widely, suggesting significant uncertainty about growth and discount rates.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore DXCM

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples